<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38586072</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Monitoring the evolution of vaccine-derived poliovirus in East and Southern African countries, 2010 - 2021.</ArticleTitle><Pagination><StartPage>31</StartPage><MedlinePgn>31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">31</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2024.47.31.39945</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">the Africa region was certified indigenous wild poliovirus-free in August 2020. Countries in East and Southern Africa have, during acute flaccid paralysis (AFP) and environmental surveillance (ES), detected equally concerning vaccine-derived polioviruses (VDPVs) that have not been systematically documented to guide programming in the sub-region. The study documents trends and salient observations of the VDPVs by country of detection, for 11 years from 2010 to 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">we conducted secondary data analysis, a descriptive study design, by deploying field and laboratory of AFP and environmental surveillance databases of the 20 East and Southern African countries from 2010 to 2021.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">a total of 318 VDPVs were reported over the study period. The majority were from AFP cases (58.8%) and the rest equally distributed between healthy community children and environmental surveillance sources. More polioviruses were detected after 2016 than during the period before. We observed that more boys were affected by VDPVs compared to girls. Children under 5 years were more affected than other age groups, with a mean age of 3.6 years. Delay of samples in the field seemed to increase the likelihood of not reporting VDPVs and not mounting timely public health detailed investigations and vaccination responses.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">the study provides useful evolutional trends of VDPVs for surveillance and vaccination programming. We also noted that the VDPV2s have been increasing after the 2016 tOPV to oral polio vaccine (bOPV) switch. The COVID-19 pandemic emergence in 2020, led to a decline in AFP, ES surveillance, and immunization activities. Our findings point to the need to implement enhanced tailored childhood immunization recovery strategies and to speed up the use of inactivated polio vaccine (IPV) to boost population immunity.</AbstractText><CopyrightInformation>Copyright: Charles Byabamazima et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Byabamazima</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>World Health Organization, Inter-Country Support Team Office for East and Southern Africa, Belvedere, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masvikeni</LastName><ForeName>Brine</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>World Health Organization, Inter-Country Support Team Office for East and Southern Africa, Belvedere, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsande</LastName><ForeName>Reggis</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manyanga</LastName><ForeName>Daudi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>World Health Organization, Inter-Country Support Team Office for East and Southern Africa, Belvedere, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011054">Poliovirus Vaccine, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011054" MajorTopicYN="N">Poliovirus Vaccine, Inactivated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000353" MajorTopicYN="N" Type="Geographic">Africa, Southern</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vaccine-derived poliovirus</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">classification</Keyword><Keyword MajorTopicYN="N">polio eradication</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38586072</ArticleId><ArticleId IdType="pmc">PMC10998255</ArticleId><ArticleId IdType="doi">10.11604/pamj.2024.47.31.39945</ArticleId><ArticleId IdType="pii">PAMJ-47-31</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ. 2004 Jan;82(1):16–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2585883</ArticleId><ArticleId IdType="pubmed">15106296</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Laboratory surveillance for wild and vaccine-derived polioviruses-worldwide, January 2008-June 2009. MMWR Morb Mortal Wkly Rep. 2009 Sep 4;58(34):950–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19730408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan F, Datta SD, Quddus A, Vertefeuille JF, Burns CC, Jorba J, et al. Progress Toward Polio Eradication-Worldwide, January 2016-March 2018. MMWR Morb Mortal Wkly Rep. 2018 May 11;67(18):524–528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944975</ArticleId><ArticleId IdType="pubmed">29746452</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebisi YA, Eliseo-Lucero Prisno D, 3rd, Nuga BB. Last fight of wild polio in Africa: Nigeria's battle. Public Health Pract (Oxf) 2020 Nov 1;:100043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528738</ArticleId><ArticleId IdType="pubmed">34173577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekwebelem OC, Nnorom-Dike OV, Aborode AT, Ekwebelem NC, Aleke JC, Ofielu ES. Eradication of wild poliovirus in Nigeria: Lessons learnt. Public Health Pract (Oxf) 2021 May 15;:2–100144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9461633</ArticleId><ArticleId IdType="pubmed">36101607</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa Regional Commission for the Certification of Poliomyelitis Eradication Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Lancet Glob Health. 2020 Oct;8(10):e1345–e1351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525084</ArticleId><ArticleId IdType="pubmed">32916086</ArticleId></ArticleIdList></Reference><Reference><Citation>Shet A, Carr K, Danovaro-Holliday MC, Sodha SV, Prosperi C, Wunderlich J, et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health. 2022 Feb;10(2):e186–e194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691849</ArticleId><ArticleId IdType="pubmed">34951973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Diop OM, Iber J, Henderson E, Sutter RW, Wassilak SGF, et al. Update on Vaccine-Derived Polioviruses-Worldwide, January 2016-June 2017. MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1185–1191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689216</ArticleId><ArticleId IdType="pubmed">29095803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque N, Semler BL. A 21st century perspective of poliovirus replication. PLoS Pathog. 2015 Jun 4;11(6):e1004825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4456262</ArticleId><ArticleId IdType="pubmed">26042673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopalco PL. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication. Epidemiol Infect. 2017 Feb;145(3):413–419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9507676</ArticleId><ArticleId IdType="pubmed">27866483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigna JJ. Polio eradication efforts in regions of geopolitical strife: the Boko Haram threat to efforts in sub-Saharan Africa. Afr Health Sci. 2016 Jun;16(2):584–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4994566</ArticleId><ArticleId IdType="pubmed">27605975</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Burns CC, Lyons H, Blake IM, Jafari H, Oberste MS, et al. Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame. PLoS Pathog. 2016 Jul 6;12(7):e1005728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4934862</ArticleId><ArticleId IdType="pubmed">27384947</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation (WHO) 2004 Polio laboratory manual”. WHO Libr. 2004 August;4:87–152. Accessed on 12 December 2022.</Citation></Reference><Reference><Citation>Martin J, Burns CC, Jorba J, Shulman LM, Macadam A, Klapsa D, et al. Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing-Worldwide, March-October 2021. MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):786–790.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiba Y, Hikita K, Matuba T, Chosa T, Kyogoku S, Yu J, et al. Active surveillance for acute flaccid paralysis in poliomyelitis high-risk areas in southern China. Bull World Health Organ. 2001;79(2):103–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566358</ArticleId><ArticleId IdType="pubmed">11242816</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG. Surveillance Systems to Track Progress Toward Polio Eradication-Worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep. 2017 Apr 7;66(13):359–365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657908</ArticleId><ArticleId IdType="pubmed">28384129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Why Have cVDPV2 Outbreaks Increased Globally After the Polio Immunization Strategy Switch: Challenges for the Polio Eradication Endgame. China CDC Wkly. 2020 Mar 14;2(11):176–179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8393165</ArticleId><ArticleId IdType="pubmed">34594619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>